Live Breaking News & Updates on Medical utilities mission
Stay updated with breaking news from Medical utilities mission. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Amylyx Pharmaceuticals (NASDAQ:AMLX – Free Report) had its price objective reduced by Mizuho from $4.00 to $3.00 in a research report report published on Tuesday morning, Benzinga reports. They currently have a neutral rating on the stock. A number of other equities research analysts have also weighed in on the company. The Goldman Sachs Group […]
Verrica Pharmaceuticals (NASDAQ:VRCA – Free Report) had its price target increased by HC Wainwright from $13.00 to $14.00 in a report released on Tuesday, Benzinga reports. They currently have a buy rating on the stock. Separately, Needham & Company LLC reiterated a buy rating and issued a $8.00 price objective on shares of Verrica Pharmaceuticals […]
StockNews.com upgraded shares of Aldeyra Therapeutics (NASDAQ:ALDX – Free Report) from a sell rating to a hold rating in a research report released on Tuesday morning. Several other equities analysts have also commented on the company. HC Wainwright reiterated a buy rating and issued a $10.00 target price on shares of Aldeyra Therapeutics in a […]
HC Wainwright reaffirmed their neutral rating on shares of Aadi Bioscience (NASDAQ:AADI – Free Report) in a research report released on Tuesday morning, Benzinga reports. HC Wainwright also issued estimates for Aadi Bioscience’s Q2 2024 earnings at ($0.66) EPS, Q4 2024 earnings at ($0.71) EPS, FY2024 earnings at ($2.73) EPS, Q1 2025 earnings at ($0.73) […]
StockNews.com started coverage on shares of United-Guardian (NASDAQ:UG – Free Report) in a report released on Tuesday. The firm issued a buy rating on the stock. United-Guardian Stock Performance Shares of NASDAQ UG opened at $9.27 on Tuesday. United-Guardian has a 52-week low of $5.79 and a 52-week high of $9.54. The firm has a […]
Vise Technologies Inc. grew its stake in shares of Merck & Co., Inc. (NYSE:MRK – Free Report) by 174.4% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 36,005 shares of the company’s stock after acquiring an additional 22,884 […]
Vise Technologies Inc. increased its position in shares of Eli Lilly and Company (NYSE:LLY – Free Report) by 12.1% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 4,852 shares of the company’s stock after acquiring an additional 522 shares during the period. Vise Technologies […]
Pfizer Inc. (NYSE:PFE – Get Free Report) shares traded up 1% during mid-day trading on Wednesday . The stock traded as high as $28.72 and last traded at $28.66. 8,367,983 shares traded hands during mid-day trading, a decline of 80% from the average session volume of 42,763,281 shares. The stock had previously closed at $28.38. […]
Vise Technologies Inc. raised its stake in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 8.9% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 6,986 shares of the healthcare conglomerate’s stock after acquiring an additional 573 shares during the quarter. Vise Technologies […]
Vise Technologies Inc. boosted its stake in shares of Eli Lilly and Company (NYSE:LLY – Free Report) by 12.1% during the fourth quarter, Holdings Channel reports. The firm owned 4,852 shares of the company’s stock after purchasing an additional 522 shares during the quarter. Vise Technologies Inc.’s holdings in Eli Lilly and Company were worth […]